WeVote

Bill

Bill

SD 1268

An Act relative to non-medical switching

194th Legislature (2025-2026) Introduced by Brendan Crighton

Prevents insurers from forcing medication switches unless medically necessary and physician-approved, prioritizing patient health over cost-driven medication substitutions.

House concurred
0
WeVote Research Nonpartisan
Bill Summary · SD 1268

Legislative bill overview

SD 1268 prohibits health insurance companies and pharmacy benefit managers from forcing patients to switch from their current medications to cheaper alternative drugs without medical justification. The bill requires that any medication switches be medically necessary and approved by the patient's prescribing physician, rather than driven purely by cost considerations.

Why is this important

Non-medical switching—where insurers substitute medications for financial reasons—can disrupt treatment stability for patients with chronic conditions, potentially leading to worse health outcomes, hospitalizations, or emergency care. This practice disproportionately affects people with complex medical needs who have found effective medication regimens. The bill addresses a growing concern that cost-cutting measures prioritize insurer profits over patient health continuity.

Potential points of contention

  • Insurance industry opposition: Insurers and PBMs argue that formulary management and therapeutic substitutions help control healthcare costs; restrictions could increase premium prices for consumers
  • Definition of "medical necessity": Disagreement over what constitutes legitimate medical reasons for staying on current medications versus acceptable cost-based alternatives, and who determines this
  • Implementation complexity: Determining enforcement mechanisms, appeal processes, and physician burden for justifying medication choices may create administrative challenges

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.